Digital wound measurement devices are laser assisted 3D devices that are used for measuring the dimensions such as length, width and depth of a wound. The devices monitor in documenting of progression and regression of wounds by accurate and repeatable measurement of wound size over the course of the healing process.
Hitachi Aloka Medical America, Inc. and Perceptive Solution – Notable Market Players in Digital Wound Measurement Devices Market
The digital wound measurement devices market is majorly comprised of top players such as eKare, Inc.; Kent Imaging Inc.; Wound Matrix, Inc.; Perceptive Solution; Wound Vision; Aranz Medical Limited; Tissue Analytics; Fuel 3D Technologies Limited; Hitachi Aloka Medical America, Inc.; and MolecuLight Inc.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the global digital wound measurement devices market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the digital wound measurement devices market:
| Year | News |
| Sept-2021 | Kent Imaging has announced Health Canada’s approval for SnapshotNIR V3.0 (KD204) – now available for shipping in both official languages. This upgrade provides significant feature enhancements to the imaging technology that advances tissue assessment in acute and chronic wounds. |
| Jan-2021 | Kent Imaging announced the FDA 510(k) clearance for SnapshotNIR V3.0(KD204) – now available for shipping. This upgrade provides significant feature enhancements to the imaging technology that advances tissue assessment in acute and chronic wounds. |
| Sept-2021 | Perceptive Solutions, Inc., maker of WoundZoom Wound Centric EMR and three-dimensional (3D) imaging hardware solutions, announced the release of their WoundZoom Mobile application. The new solution gives healthcare providers a more intelligent and efficient way to manage wound care across a variety of care settings with its intuitive mobile workflow application and non-contact wound measurement technology that can be accessed on a clinician’s mobile device. |
| Sept-2021 | MolecuLight Inc., announced that it has received FDA 510(k) clearance for the detection of wounds containing clinically significant levels (>104 CFU/g) of Pseudomonas aeruginosa (PA) for the previously cleared MolecuLight i:X imaging device. The i:X device visualizes fluorescence enabling the detection of wounds containing elevated levels of bacteria in wounds at the point-of-care. This new FDA clearance supports the ability of the i:X device to increase the clinician’s ability to detect the presence of Pseudomonas aeruginosa in wounds using the cyan fluorescence signal. |
